Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.
Frequently asked questions
What sector does Catheter Precision Inc. (VTAK) operate in?
Catheter Precision Inc. belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Catheter Precision Inc. (VTAK) current stock price?
As of the latest data, Catheter Precision Inc. stock price is $0.15, with a previous close of $0.15. Catheter Precision Inc. lost -$0.00 in the last trading session, representing a -0.66% loss.
What is Catheter Precision Inc. (VTAK) current market capitalization?
Catheter Precision Inc. market cap is approximately 545.03 thousand.
What is Catheter Precision Inc. (VTAK) Earnings Per Share (EPS)?
The trailing EPS is -$4.07, and the forward EPS is -$0.32.
What is Catheter Precision Inc. (VTAK) EBITDA?
Catheter Precision Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.03 million.
Does Catheter Precision Inc. (VTAK) pay dividends?
No. Catheter Precision Inc. does not pay a dividend.
When is Catheter Precision Inc. (VTAK) next earnings report?
Catheter Precision Inc. is expected to release its next earnings report on September 30, 2026.
What is Catheter Precision Inc. (VTAK) beta (volatility) score?
Catheter Precision Inc. has a beta of 0.465, indicating lower volatility than the overall market.
